In vitro activity of chlorogenic acid against Aspergillus fumigatus biofilm and gliotoxin production

被引：6
|
作者：
Kong, Jin-Liang [1 ]
Luo, Jing [1 ]
Li, Bing [1 ]
Dong, Bi-Ying [1 ]
Huang, Hong [1 ]
Wang, Ke [1 ]
Wu, Li-Hong [1 ]
Chen, Yi-Qiang [1 ]
机构：
[1] Guangxi Med Univ, Inst Resp Dis, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China
来源：
EXPERIMENTAL AND THERAPEUTIC MEDICINE | 2017年 / 13卷 / 06期
基金：
中国国家自然科学基金;
关键词：
chlorogenic acid; Aspergillus fumigatus; biofilm; amphotericin B; gliotoxin; AMPHOTERICIN-B;
D O I：
10.3892/etm.2017.4317
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Aspergillus (A.) fumigatus, one of the most common causes of life-threatening fungal infections in immunocompromised patients, shows resistance to antifungal agents as has a high propensity to forming a biofilm. The present study aimed to investigate the effects of chlorogenic acid (CRA) on A. fumigatus biofilm formation and integrity. Confocal laser scanning microscopy was performed to determine the inhibitory effects of CRA against A. fumigatus biofilm formation. Transmission electron microscopy was performed to investigate the ultrastructural changes of A. fumigatus biofilm after CRA exposure. High-performance liquid chromatography and reverse-transcription quantitative PCR were performed to determine the expression of gliotoxin production in biofilm culture. The results showed that CRA at sub-minimum inhibitory concentrations inhibited A. fumigatus biofilm formation. In addition, CRA could decreased the gliotoxin production in the biofilm culture supernatant through inhibiting the expression of master genes involved in gliotoxin biosynthesis. The present study provided useful information for the development of novel strategies to reduce the incidence of A. fumigatus biofilm-associated diseases.
引用
收藏
页码：2637 / 2644
页数：8
相关论文
共 50 条
  • [41] Anti-melanogenic activity of Myristica fragrans extract against Aspergillus fumigatus using phenotypic based screening
    Hoda, Shanu
    Vermani, Maansi
    Joshi, Rajesh K.
    Shankar, Jata
    Vijayaraghavan, Pooja
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 67
  • [42] In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates
    Jemel, Sana
    Raveloarisaona, Yannick
    Bidaud, Anne-Laure
    Djenontin, Elie
    Kallel, Aicha
    Guillot, Jacques
    Kallel, Kalthoum
    Botterel, Francoise
    Dannaoui, Eric
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 12
  • [43] Synthetic cystic fibrosis sputum medium diminishes Burkholderia cenocepacia antifungal activity against Aspergillus fumigatus independently of phenylacetic acid production
    Lightly, Tasia Joy
    Phung, Ryan R.
    Sorensen, John L.
    Cardona, Silvia T.
    CANADIAN JOURNAL OF MICROBIOLOGY, 2017, 63 (05) : 427 - 438
  • [44] Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus
    Shekhova, Elena
    Kniemeyer, Olaf
    Brakhage, Axel A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (11)
  • [45] In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions
    Fakhim, Hamed
    Vaezi, Afsane
    Dannaoui, Eric
    Sharma, Cheshta
    Mousavi, Bita
    Chowdhary, Anuradha
    Meis, Jacques F.
    Badali, Hamid
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (03) : 266 - 268
  • [46] In vitro and in vivo Efficacy of a Synergistic Combination of Itraconazole and Verapamil Against Aspergillus fumigatus
    Zeng, Qiuqiong
    Zhang, Zheng
    Chen, Peiying
    Long, Nanbiao
    Lu, Ling
    Sang, Hong
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [47] Interactions of Aspergillus fumigatus and Stenotrophomonas maltophilia in an in vitro Mixed Biofilm Model: Does the Strain Matter?
    Melloul, Elise
    Roisin, Lolita
    Durieux, Marie-Fleur
    Woerther, Paul-Louis
    Jenot, Delphine
    Risco, Veronica
    Guillot, Jacques
    Dannaoui, Eric
    Decousser, Jean-Winoc
    Botterel, Francoise
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [48] In vitro and in vivo antimicrobial effects of domiphen combined with itraconazole against Aspergillus fumigatus
    Yang, Huan
    Gu, Yufan
    He, Zhiqiang
    Wu, Jia-Nan
    Wu, Chen
    Xie, Yuhan
    You, Yuxin
    Yang, Yijia
    Zhou, Xinyu
    Liu, Yi
    Du, Wenlong
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [49] Evaluation of the In Vitro Activity of Voriconazole As Predictive of In Vivo Outcome in a Murine Aspergillus fumigatus Infection Model
    Salas, Valentina
    Javier Pastor, F.
    Calvo, Enrique
    Sutton, Deanna A.
    Fothergill, Annette W.
    Guarro, Josep
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) : 1404 - 1408
  • [50] Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B
    Singh, J
    Rimek, D
    Kappe, R
    MYCOSES, 2006, 49 (02) : 96 - 103
12345